Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|17|2532-2548

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.17, 2016-05, pp. : 2532-2548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Designing Dendrimers for Drug Delivery and Imaging: Pharmacokinetic Considerations

By Wijagkanalan Wassana   Kawakami Shigeru   Hashida Mitsuru  

Pharmaceutical Research, Vol. 28, Iss. 7, 2011-07 ,pp. : 1500-1519

Springer Publishing Company

Access to resources Recommend Favorite

Intravesical Drug Delivery: Pharmacokinetic and Clinical Considerations

By Highley M.S.  

Clinical Pharmacokinetics, Vol. 37, Iss. 1, 1999-07 ,pp. : 59-73

Adis International

Access to resources Recommend Favorite

-Adrenergic Blockers in Systemic Hypertension: Pharmacokinetic Considerations Related to the Current Guidelines

By Frishman W.H.  

Clinical Pharmacokinetics, Vol. 41, Iss. 7, 2002-01 ,pp. : 505-516

Adis International

Access to resources Recommend Favorite

Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations

By Thorne R.G.  

Clinical Pharmacokinetics, Vol. 40, Iss. 12, 2001-01 ,pp. : 907-946

Adis International

Access to resources Recommend Favorite

Regional Distribution and Kinetics of Inhaled Pharmaceuticals.

By  

Current Pharmaceutical Design, Vol. 6, Iss. 16, 2000-11 ,pp. : 1631-1651

Bentham Science Publishers

Access to resources Recommend Favorite